Operator Finance Network Zhang Yang/Wen
At the end of last year, the National Joint Procurement Office announced the proposed winning results of the sixth batch of national centralized drug procurement ( insulin special project), among which the complete series of insulin products of Tonghua Dongbao successfully won the bid for Class B.
As the vice president of Tonghua Dongbao, Chen Hong has worked in the company for many years. She has previously presided over many studies such as the research and development of recombinant human insulin series preparations. However, this executive is still very low-key and does not often attend the company's public activities. Next, the operator Finance tries to reveal his personal experience.
Public information shows that Chen Hong was born in June 1974, is 48 years old this year, and is a practicing pharmacist . He graduated from , Shenyang Pharmaceutical University, in 1998; graduated from , Jilin University, in 2006; and then completed his in-service doctorate in economics at , Wuhan University, in 2016.
According to Tonghua Dongbao's annual report, Chen Hong has been engaged in the research and development of traditional Chinese medicine and biological products, and has presided over many researches such as screening and application research of peroxide mimic enzymes.
In Dongbao, Tonghua, Chen Hong was once the company's product development department manager, deputy general manager and chief engineer. At present, he is currently mainly responsible for the development of improved new Chinese medicine drugs, the development of traditional Chinese medicine compound preparations in ancient classic prescriptions, and the quality management of traditional Chinese medicine production.
Since 2011, Chen Hong has been the deputy general manager of Tonghua Dongbao, and has worked in this position for more than ten years.
In April this year, Tonghua Dongbao (600867) released its 2021 annual report. During the reporting period, the company achieved operating income of 3.267 billion yuan, a year-on-year increase of 12.99%; and achieved net profit attributable to shareholders of listed companies of 1.308 billion yuan, a year-on-year increase of 40.69%.
Among them, Chen Hong, who has been the vice president of for more than ten years, had an annual salary of 581,700 yuan last year. Although has already received good treatment in listed companies, Su Fan, who is also the deputy general manager of in the company, has an annual salary of 864,200 yuan, and Zhang Wenhai, director and deputy general manager, has an annual salary of 1.183,200 yuan. Operator Finance has no way of knowing why such a big gap arises.
Interestingly, Chen Hong is still the few executives among the company's senior executives who hold Tonghua Dongbao shares. Although he only holds more than 290,000 shares, based on the closing price on September 27 this year, 8.71 yuan per share, it is also a considerable amount, which is several times that of Chen Hong's annual salary.
How Chen Hong will develop in Tonghua Dongbao in the future? Operator Finance will continue to pay attention to how Chen Hong will develop.
